314 related articles for article (PubMed ID: 27253331)
1. Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.
Zhou Q; Li W; Leng B; Zheng W; He Z; Zuo M; Chen A
PLoS One; 2016; 11(6):e0155495. PubMed ID: 27253331
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis.
Wang X; Shi XQ; Zeng PW; Mo FM; Chen ZH
Oncotarget; 2018 May; 9(36):24514-24524. PubMed ID: 29849957
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Circulating Cell-Free DNA for Correlation with Lung Cancer Survival: A Systematic Review and Meta-Analysis.
Cargnin S; Canonico PL; Genazzani AA; Terrazzino S
J Thorac Oncol; 2017 Jan; 12(1):43-53. PubMed ID: 27543256
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: A PRISMA-compliant systematic review and meta-analysis.
Zheng WF; Zhan J; Chen A; Ma H; Yang H; Maharjan R
Medicine (Baltimore); 2019 Dec; 98(51):e18496. PubMed ID: 31861035
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
[TBL] [Abstract][Full Text] [Related]
7. Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
Gu Y; Wan C; Qiu J; Cui Y; Jiang T; Zhuang Z
PLoS One; 2020; 15(2):e0224001. PubMed ID: 32027658
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.
He X; Chi Y; Peng J; Hu W; Ding C; Li B
J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
[TBL] [Abstract][Full Text] [Related]
10. Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer:A pooled analysis of individual studies.
Zhou Q; Zuo MZ; He Z; Li HR; Li W
Int J Biol Markers; 2018 Apr; ():1724600818766500. PubMed ID: 29683066
[TBL] [Abstract][Full Text] [Related]
11. Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
Lin J; Qin J; Sangvatanakul V
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):81-5. PubMed ID: 23228410
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
Yang X; Zhang K; Zhang C; Peng R; Sun C
BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
[TBL] [Abstract][Full Text] [Related]
13. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis.
Yin C; Luo C; Hu W; Ding X; Yuan C; Wang F
Dis Markers; 2016; 2016():3825819. PubMed ID: 27766004
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.
Hou F; Sun XD; Deng ZY
Medicine (Baltimore); 2023 Feb; 102(7):e32928. PubMed ID: 36800605
[TBL] [Abstract][Full Text] [Related]
16. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
Lu Y; Li L
Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
[No Abstract] [Full Text] [Related]
18. Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis.
Jia MM; Deng J; Cheng XL; Yan Z; Li QC; Xing YY; Fan DM; Tian XY
Oncotarget; 2017 Feb; 8(6):9660-9671. PubMed ID: 28039447
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Serum Kallikrein-Related Peptidases for Ovarian Cancer: A Systematic Review and Meta-Analysis.
Lan Z; Wang F; Yu X; Zeng X; Xi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1366-74. PubMed ID: 27465901
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: A systematic review with meta-analysis.
Jiang T; Zhai C; Su C; Ren S; Zhou C
Lung Cancer; 2016 Oct; 100():63-70. PubMed ID: 27597282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
